The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Century Therapeutics Inc shares valued at $1,375 were sold by Pfeiffenberger Brent on Mar 10 ’25. At $0.61 per share, Pfeiffenberger Brent sold 2,235 shares. The insider’s holdings dropped to 1,190,310 shares worth approximately $0.67 million following the completion of this transaction.
Also, Russotti Gregory sold 2,360 shares, netting a total of over 1,451 in proceeds. Following the sale of shares at $0.61 each, the insider now holds 272,573 shares.
Before that, Farid Adrienne had sold 2,359 shares from its account. In a trade valued at $1,451, the Chief Operations Officer traded Century Therapeutics Inc shares for $0.61 each. Upon closing the transaction, the insider’s holdings decreased to 2,359 shares, worth approximately $73761.52.
As published in their initiating research note from Rodman & Renshaw on August 08, 2024, Century Therapeutics Inc [IPSC] has been a Buy and the price target has been revised to $6. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late August. As of December 27, 2022, Chardan Capital Markets has initiated its “Buy” rating for IPSC. Earlier on October 31, 2022, Guggenheim initiated its rating. Their recommendation was “a Buy” for IPSC stock.
Analyzing IPSC Stock Performance
During the last five days, there has been a drop of approximately -14.73%. Over the course of the year, Century Therapeutics Inc shares have dropped approximately -44.70%. Shares of the company reached a 52-week high of $1.1850 on 01/08/25 and a 52-week low of $0.5500 on 03/13/25. A 50-day SMA is recorded $0.8072, while a 200-day SMA reached $1.6108.
Support And Resistance Levels for Century Therapeutics Inc (IPSC)
According to the 24-hour chart, there is a support level at 0.5391, which, if violated, would cause prices to drop to 0.5198. In the upper region, resistance lies at 0.5887. The next price resistance is at 0.6190. RSI (Relative Strength Index) is 24.11 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0539, which suggests the price will decrease in the coming days. Percent R is at 95.82%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
